Thromboprophylaxis and Bariatric Surgery

Summary

This trial is an assessment of the efficacy of three thromboprophylaxis regimens in two types of bariatric surgery. \- gastric banding and gastric bypass on anti-Xa activity levels The study includes two groups of 150 patients scheduled for gastric banding or gastric bypass. Assessment of anti-Xa levels before and 4 hours after the injections from day 0 to 2 in order to determine the best prophylactic regimen allowing expected values ranged between 0.3 and 0.5 IU / ml.

Timeline

Start

2006-11

Primary completion

2012-11

Completion

2012-12

Publications

• Amaral FC, Baptista-Silva JC, Nakano LC, Flumignan RL. Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery. Cochrane Database Syst Rev. 2022 Nov 22;11(11):CD013683. doi: 10.1002/14651858.CD013683.pub2.

Drugs

Indications